₹1,668.30
+27.30 (+1.66%)
As of 17 Sept 2026, Aurobindo Pharma Ltd share price is ₹1,668.30. The stock opened at ₹1,668.30 and had closed at ₹1,641.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,066.00 and a high of ₹1,706.70. In terms of performance, Aurobindo Pharma Ltd share price has increased by 29.31% over the past six months and has increased by 45.41% over the last year.
AUROPHARMA Stock Price Chart
Aurobindo Pharma Ltd Overview
Market cap₹94,420 Crs
Volume2,070
Prev. Close₹1,641.00
Year range₹1,066.00 - ₹1,706.70
ISININE406A01037
About AUROPHARMA
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.
Aurobindo Pharma Ltd Historical Performance
1 Month Return0.98%
6 Month Return28.27%
3 Year Return82.59%
3 Month Return17.63%
1 Year Return50.28%
5 Year Return130.33%
AUROPHARMA Futures & Options
Aurobindo Pharma Ltd Fundamentals
ROCE(TTM)12.51%
P/E Ratio (TTM)36.42
P/B Ratio4.16
Debt to Equity0.19
ROE10.63%
EPS (TTM)45.29
Dividend Yield0.25%
Book Value394.82
Profit Margin23.66%
Operating Margin26.01%
Aurobindo Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 11,759.25 | 11,261.42 | 11,261.70 | 8,900.92 | 11,958.13 |
| EBITDA | 3,662.09 | 2,885.69 | 2,840.10 | 1,948.83 | 2,069.68 |
| Net Profit | 2,414.80 | 1,746.79 | 1,954.14 | 1,227.11 | 1,454.71 |
| EPS | 41.58 | 29.97 | 33.35 | 21.00 | 24.83 |
Aurobindo Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,623.82 |
| Resistance 1 (R1) | 1,656.87 |
| Pivot Point | 1,639.68 |
Aurobindo Pharma Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 08-Aug-2025 | 04-Aug-2025 | 08-Aug-2025 | Interim | ₹4.00 |
| 20-Feb-2024 | 10-Feb-2024 | 20-Feb-2024 | Interim 2 | ₹1.50 |
| 20-Nov-2023 | 09-Nov-2023 | 20-Nov-2023 | Interim 1 | ₹3.00 |
| 17-Feb-2023 | 09-Feb-2023 | 17-Feb-2023 | Interim 1 | ₹3.00 |
| 06-Jun-2022 | 30-May-2022 | 07-Jun-2022 | Interim 4 | ₹4.50 |
AUROPHARMA Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| M R Kumar | Chairman |
| Kambam Nityananda Reddy | Vice Chairman & M.D. |
| M Madan Mohan Reddy | E D & Wholetime Directorector |
Aurobindo Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,858.60+0.28% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,287.50+1.41% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,812.50+0.00% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Aurobindo Pharma Ltd today is ₹1,668.30 on NSE and ₹1,668.30 on BSE.
- The 52-week high of Aurobindo Pharma Ltd is ₹1,706.70, while the 52-week low is ₹1,066.00.
- The current market capitalisation of Aurobindo Pharma Ltd is approximately ₹94,420 crore.
- The P/E (Price-to-Earnings) ratio of Aurobindo Pharma Ltd is 19.92. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Aurobindo Pharma Ltd is 1.98. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Aurobindo Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for AUROPHARMA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Aurobindo Pharma Ltd has delivered a return of approximately 82.59%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Aurobindo Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 51.88% promoters, -0.33% FIIs, 25.10% DIIs, and 5.36% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
